Clinical Trials Sponsored by Link America, Inc

Total 1225 results

Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Broad Effectiveness: Study With Aripiprazole

Schizophrenia | Schizoaffective Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Subjects With Alcoholism

Alcoholism

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder | Body Weight Change

United States, Brazil, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Parkinson's Disease | Psychoses

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Effect on Cognitive Function of a Treatment With Aripiprazole

Schizophrenia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

Schizophrenia

Belgium, France, Netherlands, Portugal, Spain
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

Schizophrenia and Schizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole Oral Acceptability Trial

Schizophrenia

United States
Shirley Ryan AbilityLab
Takeda Pharmaceuticals North America, Inc.

Completed

Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation

Constipation

United States
Tufts Medical Center
Takeda Pharmaceuticals North America, Inc.

Completed

Uric Acid and Long-term Outcomes in Chronic Kidney Disease

Chronic Kidney Disease

United States
Johns Hopkins University
Toshiba America Medical Systems, Inc.

Completed

Diagnostic Accuracy of Multi-Detector Spiral Computed Tomography Angiography Using 64 Detectors (CORE-64)

Coronary Artery Disease
Mitsubishi Tanabe Pharma America Inc.
Massachusetts General Hospital

Active, not recruiting

Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
Pursuit Vascular, Inc.
Fresenius Medical Care North America

Completed

Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap

End Stage Renal Disease (ESRD)

United States
Massachusetts General Hospital
Takeda Pharmaceuticals North America, Inc.

Completed

Vortioxetine for Menopausal Depression

Depression | Hot Flashes | Sleep | Menopause | Vasomotor Disturbance

United States
University of Michigan
Takeda Pharmaceuticals North America, Inc.

Completed

Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation

Irritable Bowel Syndrome | Constipation

United States
University of Rochester
Takeda Pharmaceuticals North America, Inc.

Terminated

Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD

Gastroesophageal Reflux | GERD

United States
SOLTI Breast Cancer Research Group
Sysmex America, Inc.

Completed

Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer (SOLO-1)

Breast Cancer

Spain
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Bipolar Disorder

United States, Puerto Rico
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in Patients With Acute Mania

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Schizophrenia Trial of Aripiprazole

Schizophrenia

Austria, United Kingdom, France, Spain, Sweden, Czech Republic, Denmark, Finland, Germany
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder

Bipolar Disorder

France, Portugal, Spain, Italy, Germany, South Africa, United Kingdom, United States, Russian Federation, Poland, Czech Republic, Hungary, Netherlands, Estonia, Australia, Bulgaria, Switzerland
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Withdrawn

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar Disorder

United States, India
University of Arkansas
Takeda Pharmaceuticals North America, Inc.

Completed

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Constipation | Cystic Fibrosis

United States
Trillium Health Centre
Toshiba America Medical Systems, Inc.

Unknown

Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT

Coronary Artery Disease Amenable to Bypass Graft Surgery

Canada
Lancaster General Hospital
Astellas Pharma Inc; Toshiba America Medical Systems, Inc.

Completed

Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting

Coronary Artery Disease

United States
Intermountain Health Care, Inc.
Deseret Foundation; Toshiba America Medical Systems, Inc.

Completed

Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64 (faCTor-64)

Coronary Artery Disease

United States
Nuseed Americas Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Evaluation of the Pharmacokinetics, Safety and Effects of NutriterraTM in Healthy Adults

Healthy

Canada
Vifor (International) Inc.
Labcorp Corporation of America Holdings, Inc

Completed

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia (VITHAL)

Beta-Thalassemia | Non-transfusion-dependent Thalassemia

Greece, Israel, Italy, Lebanon, Thailand
Brigham and Women's Hospital
E-ink corporation

Unknown

Virtual White Boards for Patient Satisfaction

Emergencies | Covid19 | Satisfaction, Patient | Satisfaction | Information Disclosure

United States
University of Arizona
American Cancer Society, Inc.

Recruiting

Symptom Management for Rural-Urban Cancer Survivors and Caregivers

Cancer | Psychological Distress | Informal Caregivers | Cancer Survivors

United States
Oregon State University
American Cancer Society, Inc.

Recruiting

Opening the Conversation Study

Breast Cancer | Gynecologic Cancer

United States
Takeda
Shire; Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura (TTP)

China, United States, France, Japan, Poland, Germany, Austria, Spain, Italy, Switzerland, United Kingdom
American Thrombosis and Hemostasis Network
Genentech, Inc.

Active, not recruiting

ATHN 7: Hemophilia Natural History Study (ATHN 7)

Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without Inhibitor

United States
Boston Medical Center
American Cancer Society, Inc.

Enrolling by invitation

Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (DOSI)

Breast Cancer

United States
Shire
Takeda Development Center Americas, Inc.

No longer available

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Angioedema | Hereditary Angioedema (HAE)

United States, Canada, Germany, Hungary, Spain
Shire
Takeda Development Center Americas, Inc.

Active, not recruiting

An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

Metachromatic Leukodystrophy (MLD)

Denmark, Germany, Japan, Australia, France, Brazil, Czechia
Shire
Takeda Development Center Americas, Inc.

Completed

A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor

Angioedema

United States, France, Netherlands, Spain, Hungary, Italy, Canada, Poland, Japan, Germany
American Regent, Inc.
Duke Clinical Research Institute

Completed

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency (HEART-FID)

Heart Failure | Iron-deficiency

United States, Canada, Australia, Bulgaria, Georgia, New Zealand, Latvia, Hungary, Poland, Czechia, Lithuania, Russian Federation, Ukraine
Shire
Takeda Development Center Americas, Inc.

Completed

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Cytomegalovirus (CMV)

United States, China, Spain, Belgium, Australia, Germany, Italy, Canada, France, Croatia, Singapore, United Kingdom, New Zealand, Korea, Republic of, Russian Federation, Poland, Austria, Greece, Switzerland, Czechia, Hungary, Israel, Turk...
Shire
Takeda Development Center Americas, Inc.

Terminated

Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE)

United States
Massachusetts General Hospital
American Cancer Society, Inc.

Completed

Version 2 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)

Smoking Cessation | Smoking, Tobacco

United States
Massachusetts General Hospital
American Cancer Society, Inc.

Completed

Survivorship Sleep Program

Cancer | Insomnia

United States
Shire
Takeda Development Center Americas, Inc.

Withdrawn

Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia

COVID-19 Pneumonia
Bausch Health Americas, Inc.
Bausch & Lomb Incorporated

Completed

EYEFILL® C. -US Viscoelastic Clinical Investigation

Cataract

United States
Bausch Health Americas, Inc.
Dow Pharmaceutical Sciences

Completed

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
University of Miami
Bausch Health Americas, Inc.

Terminated

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Hepatic Encephalopathy

United States
NYU Langone Health
Bausch Health Americas, Inc.

Terminated

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.

Hepatic Encephalopathy

United States

Clinical Trials Sponsored by Link America, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations